Immuno-oncology agents are effective in treating classic Hodgkin’s lymphoma Presented ByDr Marc André, Centre Hospitalier Universitaire UCL Namur, Belgium TrialCheckMate 205; KEYNOTE-087 ConferenceEHA 2021 5 August, 2021 12:26